Asia Pacific Travel Vaccines Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)

No. of Pages: 124
Report Code: BMIRE00025509
Category: Life Sciences
Asia Pacific Travel Vaccines Market
Buy Now

The travel vaccines market in Asia Pacific is expected to grow from US$ 486.56 million in 2021 to US$ 1,023.07 million by 2028; it is estimated to grow at a CAGR of 11.2% from 2021 to 2028.

Rising awareness related to the benefits of vaccines is the major factor leading to the growth of the travel vaccines market in the region. Most countries have mandated vaccination against various infectious diseases. However, there is a lack of awareness about vaccination in most low–and middle–income countries. Many countries conduct awareness campaigns for vaccination. In 2018, 17 countries in the Western Pacific region had celebrated “world immunization week” with the theme of “protected together VaccinesWork.” Moreover, international organizations offer vaccines to children in low- and middle-income countries against pneumonia, HPV infections, and rotavirus in Asia Pacific. On the other hand, vaccination awareness is also an important part of the public health system among developed countries. Such initiatives are increasing the immunization and production of vaccines to offer growth opportunities for the market. Also, it will educate people regarding travel vaccines. As there has been an increase in travel across regions in search of better job opportunities and health, domestic and international travelers are always at a risk of exposing to infectious diseases and may transmit them to others before or after travel. Therefore, such initiatives and programs are creating a scope for travel vaccines and establish a robust market in low- and middle-income countries. 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific travel vaccines market. The Asia Pacific travel vaccines market is expected to grow at a good CAGR during the forecast period.     

Asia Pacific Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Travel Vaccines Market Segmentation             

Asia Pacific travel vaccines market is segmented into product, application, and country. The Asia Pacific travel vaccines market, based on product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. The Asia Pacific travel vaccines market, based on application, is segmented into domestic travel and outbound travel. In 2021, the outbound travel segment held the largest market share. Based on country, the Asia Pacific travel vaccines market  is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific.    

Abbott; Bharat Biotech; Emergent BioSolutions Inc.; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; and Sanofi are among the leading companies in the travel vaccines market in the region.   

Asia Pacific Travel Vaccines Market Strategic Insights

global-market-strategic-framework
Get more information on this report

Asia Pacific Travel Vaccines Market Segmentation Analysis

Asia Pacific Travel Vaccines Market Report Highlights

Asia Pacific Travel Vaccines Report Scope

Report Attribute Details
Market size in 2021 US$ 486.56 Million
Market Size by 2028 US$ 1,023.07 Million
CAGR (2021 - 2028) 11.2%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Hepatitis A
  • Hepatitis B
  • Meningococcal Vaccines
By Application
  • Domestic Travel and Outbound Travel
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Abbott
  • Bharat Biotech
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
Get more information on this report

Asia Pacific Travel Vaccines Market Country and Regional Insights

asia-pacific-travel-vaccines-market
Get more information on this report

The List of Companies - Asia Pacific Travel Vaccines Market

  1. Abbott
  2. Bharat Biotech
  3. Emergent BioSolutions Inc.
  4. GlaxoSmithKline plc
  5. Merck & Co., Inc.
  6. Novartis AG
  7. Pfizer Inc.
  8. Sanofi
Frequently Asked Questions
How big is the Asia Pacific Travel Vaccines Market?

The Asia Pacific Travel Vaccines Market is valued at US$ 486.56 Million in 2021, it is projected to reach US$ 1,023.07 Million by 2028.

What is the CAGR for Asia Pacific Travel Vaccines Market by (2021 - 2028)?

As per our report Asia Pacific Travel Vaccines Market, the market size is valued at US$ 486.56 Million in 2021, projecting it to reach US$ 1,023.07 Million by 2028. This translates to a CAGR of approximately 11.2% during the forecast period.

What segments are covered in this report?

The Asia Pacific Travel Vaccines Market report typically cover these key segments-

  • Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines)
  • Application (Domestic Travel and Outbound Travel)

What is the historic period, base year, and forecast period taken for Asia Pacific Travel Vaccines Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Travel Vaccines Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Asia Pacific Travel Vaccines Market?

    The Asia Pacific Travel Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • Bharat Biotech
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Who should buy this report?

    The Asia Pacific Travel Vaccines Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Travel Vaccines Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now

    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)